Shrey Thaker ‘22 The centerpiece of clinical struggle against cancer is the recurrence of the tumor following extensive chemotherapy. The most common chemotherapeutic agent dispatched to patients suffering from colon cancer is known as 5-Fluorouracil (5-FU) and its main mechanism of action includes inducing apoptosis by inflicting DNA damage and triggering the cell’s natural apoptotic pathways. While the initial effect of tumor cell death is … Continue reading Cancer Cell Debris Generated by the Longstanding Chemotherapeutic 5-Fluorouracil is Linked to Oncogenic Inflammation
Nomrota Majumder ‘21 Costunolide, a sesquiterpene lactone extracted from Radix Aucklandiae, is shown to have powerful activity against multiple cancer forms. However, the effects of costunolide has not yet been investigated with gastric cancer, or the formation and growth of malignant cancer cells lining the stomach. As the fifth most common cancer in the world, and the third leading cause of cancer related death in … Continue reading Costunolide: A Potential Drug Molecule for Fighting Gastric Cancer
By Riya Gandhi ‘22 In the current day and age, therapeutic procedures for breast cancer–such as chemotherapy, radiation therapy, and surgery–are at the forefront of the initiative to manage cancer effectively. Across the globe, there are nations where the resources for such treatments are readily available. However, what about the low to middle income nations? Unfortunately, many of these countries, which hold higher rates of … Continue reading Utilizing Heat Shock Protein 90 in Breast Cancer Imaging: A Cheaper Alternative?
By Riya Gandhi ‘22 Due to their ability to purify blood and remove wastes, the kidneys are regarded as the filtration system for the human body. As such, they are one of the most crucial organs. However, what happens one or both of your kidneys are damaged, or worse, fail completely? Such an occurrence is known as acute kidney injury (AKI) and can transpire within … Continue reading Assessing the Risk: The Susceptibility of a Cancer Patient to Acute Kidney Injury
By Riya Gandhi ‘22 The aggressive proliferation of glioblastoma cells is characteristic of glioblastoma multiforme (GBM), a fatal cancer of the brain. As much as treatments may help, patients with this cancer typically relapse. Furthermore, radiotherapy and chemotherapy unintentionally target and poison normal proliferating cells, thereby harming the wellbeing of the patients. However, under principle investigator Dr. Yufeng Shi, researchers at the Cancer Biology & … Continue reading Invasion of the Gboxins: Inhibiting the Proliferation of Glioblastoma Cells
By Nicole Zhao ’20 Numerous cancer research projects are dedicated to investigating the primary tumor and its microenvironment. Though this is undoubtedly important, the role of immune cells during cancer dispersion in the blood cells is largely uncharacterized. Circulating tumor cells (CTCs) lead to metastasis of several types of cancers and its levels are often a predictor of survival rate. These cells are often found … Continue reading Neutrophils Escort Circulating Tumor Cells and Increase Metastatic Potential
By Ellie Teng ‘21 A prominent protein in cancer research, p53, is known for its cancer fighting abilities. p53 suppresses the initiation of tumor growth by inhibiting the cancer metabolic switch from oxidative phosphorylation to glycolysis. Glycolysis is attributed to cancer metabolism and is required for tumorigenesis, or the formation of tumors. Essentially, p53 protects the genome against mutations and prevents the mutations from being … Continue reading Protein WTp53: Fights Tumors or Boosts Cancer?
By Allan Mai ‘20 BH4 is an important regulator of many bodily functions. Among its most important functions are its involvement in the production of monoamine neurotransmitters, its generation of nitric oxide, and its role in pain. However, Shane Cronin and his team recently uncovered another important function of this cofactor: proliferation of T cells, which are an integral part of the immune response. Inhibitions … Continue reading BH4’s Role in T- Cell Proliferation in Autoimmunity and Cancer
By Riya Gandhi ‘22 In recent years cancer therapy – especially cancer immunotherapy – has gained momentum and scientists’ interest has turned to immune checkpoint inhibitors (ICIs). ICIs aid in the suppression of checkpoint receptors to produce powerful immune responses against tumors. Although such a procedure is gaining momentum in clinical settings, much research must be done to legitimize this treatment for breast cancer. Under … Continue reading Inducing Tumor Cell Death by RIG-I: The Future of Breast Cancer?
By Snigdha Kanadibhotla ‘21 Fundamentally rooted in a lack of cell cycle control, cancer is predicted to affect 38.4% of Americans within their lifetimes (1). While most healthy cells are regulated by three cell cycle checkpoints, cancerous cells can bypass these regulatory systems, which leads to uncontrolled division and metastasis (the spread of cancer through the body). Considered to be a unique characteristic of cancer, … Continue reading Investigating the Link Between Cancer Cells and Embryonic Cells to Treat Cancer